Matches in Wikidata for { <http://www.wikidata.org/entity/Q91628962> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q91628962 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91628962 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91628962 description "scientific article published on 07 April 2020" @default.
- Q91628962 description "wetenschappelijk artikel" @default.
- Q91628962 description "наукова стаття, опублікована 7 квітня 2020" @default.
- Q91628962 name "Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice" @default.
- Q91628962 name "Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice" @default.
- Q91628962 type Item @default.
- Q91628962 label "Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice" @default.
- Q91628962 label "Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice" @default.
- Q91628962 prefLabel "Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice" @default.
- Q91628962 prefLabel "Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice" @default.
- Q91628962 P1433 Q91628962-4A3D1A6D-FF63-4562-B8D6-6FE3BCC3D15A @default.
- Q91628962 P1476 Q91628962-4BE55D26-F533-486C-A7B7-014A41446D78 @default.
- Q91628962 P2093 Q91628962-1D5BF523-8D82-491B-B5C4-F6D880016517 @default.
- Q91628962 P2093 Q91628962-1ED7FB36-DF8C-408A-9529-10C2F4C3623B @default.
- Q91628962 P2093 Q91628962-41054F99-F2F6-4EF4-80AC-BE1FF22EBE73 @default.
- Q91628962 P2093 Q91628962-4F2FEA53-4F1F-4FEA-9C5C-33F49EDCD3F5 @default.
- Q91628962 P2093 Q91628962-51C72CB5-BFDD-43BC-977F-65CAF57E5479 @default.
- Q91628962 P2093 Q91628962-5220B20F-2072-4BF4-8935-5AAF061A7DE0 @default.
- Q91628962 P2093 Q91628962-8E7311DE-E7E0-4158-AB4B-3EA830433D9D @default.
- Q91628962 P2093 Q91628962-C70DCC77-9B8D-4933-B38E-E311D7F00AF7 @default.
- Q91628962 P2093 Q91628962-C716F00D-6864-4E76-A705-65CA258903D1 @default.
- Q91628962 P2093 Q91628962-E701AAE9-5209-41EC-9214-353E9E457712 @default.
- Q91628962 P31 Q91628962-1DDB9314-34B9-4E2E-843B-2039B67E766D @default.
- Q91628962 P356 Q91628962-9386516B-88B1-44AB-A82F-C5123A29C4E4 @default.
- Q91628962 P577 Q91628962-6758BDB1-9411-49FE-BEA5-FF67491E37CC @default.
- Q91628962 P698 Q91628962-F929FC1E-B98A-4479-90F5-D0852A521290 @default.
- Q91628962 P356 CBR.2019.3405 @default.
- Q91628962 P698 32255676 @default.
- Q91628962 P1433 Q15766755 @default.
- Q91628962 P1476 "Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice" @default.
- Q91628962 P2093 "Agnieszka Sawicka" @default.
- Q91628962 P2093 "András Polyák" @default.
- Q91628962 P2093 "Ewa Laszuk" @default.
- Q91628962 P2093 "Lajos Balog" @default.
- Q91628962 P2093 "Piotr Garnuszek" @default.
- Q91628962 P2093 "Renata Mikołajczak" @default.
- Q91628962 P2093 "Urszula Karczmarczyk" @default.
- Q91628962 P2093 "Veronika Kovács-Haász" @default.
- Q91628962 P2093 "Wioletta Wojdowska" @default.
- Q91628962 P2093 "Zita Pöstényi" @default.
- Q91628962 P31 Q13442814 @default.
- Q91628962 P356 "10.1089/CBR.2019.3405" @default.
- Q91628962 P577 "2020-04-07T00:00:00Z" @default.
- Q91628962 P698 "32255676" @default.